OCUL: OCULAR THERAPEUTIX, INC insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $234K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-08 | Anderman Todd | Officer | $87K | yes |
| 2026-10-02 | Kaiser Peter | Officer | $70K | yes |
| 2026-10-02 | Heier Jeffrey S. | Officer | $77K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-29 | 13G amendment | BlackRock, Inc. | 7.00% | SEC |
Institutional ownership (Q2 2026)
262 institutions reported holding $1.95B of OCULAR THERAPEUTIX, INC on Form 13F (271 the quarter before). 29 opened a new position and 38 sold out. Shares held by institutions: same.
| Largest holders | Shares | Value |
|---|---|---|
| FMR LLC | 32,844,043 | $322.53M |
| Deep Track Capital, LP | 19,686,282 | $193.32M |
| BlackRock, Inc. | 19,376,555 | $190.28M |
| Avoro Capital Advisors LLC | 12,540,000 | $123.14M |
| Summer Road LLC | 12,208,296 | $119.89M |
| Venrock Adviser, LLC | 10,346,926 | $101.61M |
| VANGUARD CAPITAL MANAGEMENT LLC | 8,832,595 | $86.74M |
| Logos Global Management LP | 5,300,000 | $52.05M |
| STATE STREET CORP | 5,233,282 | $51.39M |
| GEODE CAPITAL MANAGEMENT, LLC | 5,021,092 | $49.32M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.